RxDoctor Payments Data

Jeffrey Tilkin, MD

Psychiatry · Chicago, ILNPI 1578534483

Payments from drug & device makers

$1,119in general payments, 2019–2025

Across 47 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$335
  • Neurocrine Biosciences, Inc.$198
  • Indivior Inc.$126
  • Johnson & Johnson$118
  • Teva Pharmaceuticals USA, Inc.$112
  • AbbVie$100
  • plus $131 from 4 others

What the payments were for

  • Food & beverage$1,119100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,119 in reported general payments places this provider in the 75th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$84,717
Medicare patients
211
Services billed
942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate114$313,678
Aripiprazole175$45,453
Divalproex Sodium ErDivalproex Sodium504$38,843
PerserisRisperidone12$29,548
VraylarCariprazine Hcl20$28,924
Clozapine366$20,836
CaplytaLumateperone Tosylate13$20,544
Quetiapine Fumarate355$12,315
Varenicline Tartrate32$11,334
Lurasidone Hcl92$8,626
Olanzapine301$8,536
Oxcarbazepine117$7,478
Risperidone386$6,150
Chlorpromazine Hcl26$6,119
Carbamazepine ErCarbamazepine49$4,450

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$118$313,678114 claims
Indivior Inc.Perseris$126$29,54812 claims
AbbVieVraylar$100$28,92420 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$68$20,54413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →